Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Nov 6, 2022; 10(31): 11325-11337
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11325
Figure 1
Figure 1 Flowchart of treatment of early esophageal squamous cell carcinoma in patients with cirrhosis. ESTD: Endoscopic submucosal tunnel dissection; EESCC: Esophageal squamous cell carcinoma; EVL: Esophageal variceal ligation; TIPS: Transjugular intrahepatic portosystemic shunt.
Figure 2
Figure 2 Representative case with early esophageal squamous cell carcinoma treated with endoscopic submucosal tunnel dissection. A: Esophageal lesions under white-light endoscopy; B: Esophageal iodine staining before dissection; C: Marking the margin of the esophageal lesions; D: Oral incision after submucosal injection; E: Tunnel creation by submucosal dissection; F: Submucosal dissection with an insulated tip knife; G: The wound after endoscopic submucosal tunnel dissection; H: The resected specimen was pinned on a board after iodine staining.
Figure 3
Figure 3 The flow diagram of cohort patients. ESTD: Endoscopic submucosal tunnel dissection.
Figure 4
Figure 4 Kaplan-Meier survival curves for cirrhosis group and noncirrhosis group. A: Overall survival; B: Disease-specific survival; C: Recurrence-free survival.